Intended for healthcare professionals

  1. How should cost data...
  2. How should cost data in pragmatic randomised trials be analysed?
Education And Debate

How should cost data in pragmatic randomised trials be analysed?

BMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7243.1197 (Published 29 April 2000) Cite this as: BMJ 2000;320:1197

Related articles

See more

Cited by...

  • Direct and indirect costs of paediatric asthma in the UK: a cost analysis
  • First assessment of a cost questionnaire for its agreement with administrative databases in females with stress urinary incontinence in Switzerland: a validation study
  • Task-sharing with lay counsellors to deliver a stepped care intervention to improve depression, antiretroviral therapy adherence and viral suppression in people living with HIV: a study protocol for the TENDAI randomised controlled trial
  • Healthcare costs of adverse drug reactions and potentially inappropriate prescribing in older adults: a population-based study
  • Treating common mental disorder including psychotic experiences in the primary care improving access to psychological therapies programme (the TYPPEX study): protocol for a stepped wedge cluster randomised controlled trial with nested economic and process evaluation of a training package for therapists
  • Effectiveness and cost-effectiveness of a combined lifestyle intervention compared with usual care for patients with early-stage knee osteoarthritis who are overweight (LITE): protocol for a randomised controlled trial
  • DECRYPT trial: study protocol for a phase II randomised controlled trial of cognitive therapy for post-traumatic stress disorder (PTSD) in youth exposed to multiple traumatic stressors
  • Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)
  • Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study
  • Cohort study of healthcare use, costs and diagnoses from onset to 6 months after discharge for takotsubo syndrome in Sweden
  • Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer
  • Healthcare costs attributable to congenital cytomegalovirus infection
  • Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial
  • Cost-effectiveness of planned birth in a birth centre compared with alternative planned places of birth: results of the Dutch Birth Centre study
  • The economic effects of supporting tuberculosis-affected households in Peru
  • Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden
  • Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden
  • Orthopaedics and the Physician Payments Sunshine Act: An Examination of Payments to U.S. Orthopaedic Surgeons in the Open Payments Database
  • Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial
  • Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
  • Rhinovirus infection and healthcare utilisation in prematurely born infants
  • Screening for Diabetes and Prediabetes Should Be Cost-Saving in Patients at High Risk
  • A randomised trial comparing the cost effectiveness of different emergency department healthcare professionals in soft tissue injury management
  • Exploring the cost-utility of stratified primary care management for low back pain compared with current best practice within risk-defined subgroups
  • Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial
  • Cost effectiveness of alternative planned places of birth in woman at low risk of complications: evidence from the Birthplace in England national prospective cohort study
  • Addition of a general practitioner to the accident and emergency department: a cost-effective innovation in emergency care
  • Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis
  • A cost-effectiveness analysis of an in-hospital clinical pharmacist service
  • Specialized Rheumatology Nurse Substitutes for Rheumatologists in the Diagnostic Process of Fibromyalgia: A Cost-Consequence Analysis and a Randomized Controlled Trial
  • Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis
  • Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
  • Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation
  • Nidotherapy in the treatment of substance misuse, psychosis and personality disorder: secondary analysis of a controlled trial
  • Effectiveness and cost-effectiveness of admissions to women's crisis houses compared with traditional psychiatric wards: pilot patient-preference randomised controlled trial
  • Alternatives to standard acute in-patient care in England: readmissions, service use and cost after discharge
  • Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial
  • Economic evaluation of nurse practitioners versus GPs in treating common conditions
  • Long-Term Clinical and Economic Analysis of the Endeavor Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent: 3-Year Results From the ENDEAVOR III Trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
  • Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)
  • What is the effect of a consultant presence in an acute medical unit?
  • Improving the reporting of pragmatic trials: an extension of the CONSORT statement
  • The INNOVO multicentre randomised controlled trial: neonatal ventilation with inhaled nitric oxide versus ventilatory support without nitric oxide for severe respiratory failure in preterm infants: follow up at 4-5 years
  • Cognitive-behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial
  • Elevated healthcare utilisation in young adult males with obstructive sleep apnoea
  • Accessibility, clinical effectiveness, and practice costs of providing a telephone option for routine asthma reviews: phase IV controlled implementation study
  • The cost effectiveness of behavioural graded activity in patients with osteoarthritis of hip and/or knee
  • A randomised controlled trial of acupuncture care for persistent low back pain: cost effectiveness analysis
  • Immediate computed tomography or admission for observation after mild head injury: cost comparison in randomised controlled trial
  • Pressure relieving support surfaces (PRESSURE) trial: cost effectiveness analysis
  • Mental health provision for young offenders: service use and cost
  • Relationship between Clinical Outcomes and Vascular Access Type among Hemodialysis Patients with Staphylococcus aureus Bacteremia
  • Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial
  • Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity
  • Targeted routine asthma care in general practice using telephone triage
  • Is Duplex Surveillance of Value After Leg Vein Bypass Grafting?: Principal Results of the Vein Graft Surveillance Randomised Trial (VGST)
  • Economic evaluation of donepezil in moderate to severe Alzheimer disease
  • Cost-effectiveness of telephone or surgery asthma reviews: economic analysis of a randomised controlled trial
  • Randomised controlled trial and cost consequences study comparing initial physiotherapy assessment and management with routine practice for selected patients in an accident and emergency department of an acute hospital
  • Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery
  • Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations
  • Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial
  • Virtual outreach: economic evaluation of joint teleconsultations for patients referred by their general practitioner for a specialist opinion
  • Manipulation of the Wrist for Management of Lateral Epicondylitis: A Randomized Pilot Study
  • Cost effectiveness and cost utility analysis of multidisciplinary care in patients with rheumatoid arthritis: a randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care
  • Use of cognitive therapy for relapse prevention in chronic depression: Cost-effectiveness study
  • Cost effectiveness of extended treatment with low molecular weight heparin (dalteparin) in unstable coronary artery disease: results from the FRISC II trial
  • Sertraline with or without interpersonal psychotherapy reduces dysthymia symptoms over psychotherapy alone
  • Impact of community neonatal services: a multicentre survey
  • Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis
  • Effects of community based nurses specialising in Parkinson's disease on health outcome and costs: randomised controlled trial
  • Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries
  • Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment---Helicobacter pylori positive (CADET-Hp) randomised controlled trial
  • The Maudsley long-term follow-up of child and adolescent depression: 3. Impact of comorbid conduct disorder on service use and costs in adulthood
  • Counting the cost of proton pump inhibitors
  • Mann-Whitney test is not just a test of medians: differences in spread can be important
  • Financial cost of social exclusion: follow up study of antisocial children into adulthood
  • Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care
Back to top